Becoming a global leader in biosimilars development

CuraTeQ Biologics successfully completes Phase 1 trial for Omalizumab biosimilar

Auro Peptides completes US FDA inspection with zero observations

CuraTeQ Biologics’ Trastuzumab Biosimilar receives recommendation for marketing authorization in India

CuraTeQ Biologics eyes ‘WuXi’ moment to kickstart Indian bio-CDMO sector

CuraTeQ Biologics to market Ustekinumab biosimilar to treat Crohn’s disease, arthritis

CuraTeQ Biologics announces positive Phase-3 results for Trastuzumab biosimilar

Aurobindo Pharma arm CuraTeQ expands scope of biosimilars distribution pact with Orion

Aurobindo Pharma on Tuesday said its subsidiary CuraTeQ Biologics has expanded the scope…

Aurobindo Pharma forays into biosimilars development

Aurobindo Pharma Limited is pleased to announce the acquisition of four cell culture derived biosimilar…